top of page
Open Site Navigation

Reimagining the way maternity care is delivered and experienced

Investor Relations

HeraMED Limited (HMD:ASX) is a medical data and technology company leading the digital transformation of the prenatal and postpartum experience through our revolutionary remote monitoring and maternity care platform.

Pregnancy Care Reimagined

Our Technology

HeraMED’s technology has been recognized by major medical institutions, with collaborations underway with the Mayo Clinic and the Sheba Medical Center, two of the world’s top 10 hospitals.


Through its partnerships and investment in R&D, HeraMED continues to optimize and develop the next generation of its home-based maternity monitoring technology.

More Technology

News

The latest from 
HeraMED

Interested in 
learning more?

HeraMED is the enabler of a paradigm shift - moving from the traditional, obsolete pregnancy care, which is visit and clinic centric, episodic and reactive, to the future of continuous, home-based, proactive care that focuses on the expecting mothers.

David Groberman, CEO HeraMED

Explore Our

ASX Announcements

28/10/2022

Change in substantial holding

Read more

27/10/2022

Ceasing to be a substantial holder

Start Now

27/10/2022

Change of Director's Interest Notice

Start Now

26/10/2022

Change in substantial holding

Start Now

21/10/2022

Notice of Annual General Meeting/Proxy Form

Start Now

20/10/2022

Restatement of CAPEX AUD amount on Investor Presentation

Start Now

20/10/2022

Pause in Trading

Start Now

19/10/2022

Global Update - Investor Presentation

Start Now

19/10/2022

Global Update

Start Now

20 / 20

bottom of page